Basics ADC Therapeutics SA IPO Date: May 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $132.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 3.81% Avg Daily Range (30 D): $0.05 | 3.74% Avg Daily Range (90 D): $0.06 | 3.50% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 143 Avg Trade Size (Sh.) (30 D): 167 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 287 Avg Inst. Trade: $1.34M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.39M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 503.58K         News May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Oct 31, 2024 @ 4:57 PM Cancer Antibody Drug Conjugates Market, Drugs Appr... Source: Researchandmarkets.Com Aug 6, 2024 @ 10:51 PM ADC Therapeutics berichtet über Finanzergebniss... Source: Adc Therapeutics Jul 12, 2024 @ 10:40 AM Antibody Drug Conjugates Market Insights 2018-2023... Source: Researchandmarkets.Com Jul 2, 2024 @ 4:27 PM ADC Therapeutics gewährt neuen Mitarbeitern Zut... Source: ADC Therapeutics SA Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.43 $-.36 $-.27 Diluted EPS $-1.43 $-.36 $-.27 Revenue $ 75.82M $ 23.03M $ 16.91M Gross Profit $ $ $ Net Income / Loss $ -149.84M $ -38.6M $ -30.73M Operating Income / Loss $ -125.51M $ -28.46M $ -32.44M Cost of Revenue $ $ $ Net Cash Flow $ -39.58M $ -56.17M $ -23.41M PE Ratio     Splits May 10, 2005:   7:1